New Phase 1/2 clinical trials: 2,199 posted since Nov 2024

Name: New Phase 1/2 clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Phase 1/2 clinical trials: 2,199 rows for $101.99, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 82 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/phase/phase-1-2, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

2,199 clinical studies in phase 1/2 were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 1,084 have an industry sponsor and 1,830 are recruiting or about to. The newest, NCT07926607, was posted on November 9, 2026: Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia (Second Affiliated Hospital of Nanchang University).

The request: Every new Phase 1/2 clinical trials on ClinicalTrials.gov, with the sponsor, conditions, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

2,199New trials
1,084Industry sponsored
1,830Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 2,199, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926607	Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia	Second Affiliated Hospital of Nanchang University	Phase 1/2	Not yet recruiting	Acute Myeloblastic Leukemia	55	China	clinicaltrials.gov
November 9, 2026	NCT07925801	Relacorilant in Patients With Poorly Controlled Type 2 Diabetes and Autonomous Cortisol Secretion	The University of Texas Health Science Center at San Antonio	Phase 1/2	Not yet recruiting	Type 2 Diabetes, Hypercortisolism	34	United States	clinicaltrials.gov
November 6, 2026	NCT07923838	Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease	Shanghai Jiao Tong University School of Medicine	Phase 1/2	Active not recruiting	Parkinson Disease (PD)	9	China	clinicaltrials.gov
November 6, 2026	NCT07923045	A Phase 1/2, Single-Dose, Multicenter, Dose Escalation, Clinical Trial to Evaluate the Safety and Efficacy of MR-146: An Open-Label Part 1...	Viatris Inc.	Phase 1/2	Recruiting	Neurotrophic Keratopathy	18	United States	clinicaltrials.gov
November 6, 2026	NCT07922889	Mesenchymal Stem Cell Exosomes Alone or Combined With HUVEC Exosomes in Non-Dialysis Chronic Kidney Disease	Nurhasan Agung Prabowo	Phase 1/2	Completed	Chronic Kidney Disease Stage 3, Chronic Kidney Disease Stage 4, Chronic Kidney Disease	34	Indonesia	clinicaltrials.gov
November 6, 2026	NCT07921576	Phase 1/2 Study of DS010 in Advanced Cancer Patients With Cachexia	Dartsbio Pharmaceuticals Ltd.	Phase 1/2	Recruiting	Cancer, Cachexia	58	Australia	clinicaltrials.gov
November 5, 2026	NCT07920289	Intravenously Administered PROMITIL Combined With Radiotherapy in Patients With Cisplatin-Ineligible Head and Neck Cancer Patients	Assuta Ashdod Hospital	Phase 1/2	Not yet recruiting	Head & Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma	20		clinicaltrials.gov
November 5, 2026	NCT07920172	Clinical Trial of Recombinant Herpes Zoster Vaccine (ZFA01 Adjuvant, CHO Cells)	Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.	Phase 1/2	Recruiting	Herpes Zoster	500	China	clinicaltrials.gov
November 5, 2026	NCT07920081	Psilocybin for Amblyopia - Targeting Critical Periods in Humans	Johns Hopkins University	Phase 1/2	Recruiting	Amblyopia	24	United States	clinicaltrials.gov
November 5, 2026	NCT07918261	Evaluation of Fisetin to Reduce Systemic Senescence	Steadman Philippon Research Institute	Phase 1/2	Completed	Cellular Senescence	82	United States	clinicaltrials.gov
November 4, 2026	NCT07917390	ALT-100 Monoclonal Antibody (mAb) in Bone-Predominant Metastatic Androgen Pathway Modulation Resistant (APMR) Prostate Cancer -- The...	University of Florida	Phase 1/2	Not yet recruiting	Prostate Cancer Metastatic to Bone	42		clinicaltrials.gov
November 4, 2026	NCT07915921	A Phase Ib/II Study of GFH276 in Combination With Chemotherapy (± Bevacizumab) or Cetuximab in Patients With RAS-mutant Metastatic...	Genfleet Therapeutics (Shanghai) Inc.	Phase 1/2	Not yet recruiting	CRC	150		clinicaltrials.gov
November 3, 2026	NCT07913347	Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)	Metagen Therapeutics, Inc.	Phase 1/2	Recruiting	Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate	54	Japan, United States	clinicaltrials.gov
November 3, 2026	NCT07912593	Phase 1/2, Open-label Study of ETX-929, a KRAS Inhibitor in Participants With Advanced Solid Tumors	Ensem Therapeutics	Phase 1/2	Recruiting	Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer...	320	United States	clinicaltrials.gov
November 3, 2026	NCT07912463	Phase Ib/II Trial of Serine/Glycine-Restricted Diet With Chemoradiotherapy for Rectal Cancer	Xuelei Ma MD	Phase 1/2	Not yet recruiting	Locally Advanced Rectal Cancer	126		clinicaltrials.gov
November 3, 2026	NCT07912346	Arginine-Restricted Diet Combined With Chemoradiotherapy in Neoadjuvant Rectal Cancer: A Phase Ib/II Trial	Xuelei Ma MD	Phase 1/2	Not yet recruiting	Rectal Cancer Patients	126		clinicaltrials.gov
November 3, 2026	NCT07911748	A Study of MBS314 for Injection in Participants With Relapsed/Refractory Multiple Myeloma.	Beijing Mabworks Biotech Co., Ltd.	Phase 1/2	Not yet recruiting	Multiple Myeloma	78		clinicaltrials.gov
November 3, 2026	NCT07911579	A Study of SYH2051 in Combination With Irinotecan Hydrochloride Liposome Injection in Subjects With Advanced Solid Tumors	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	Phase 1/2	Not yet recruiting	Advanced Solid Tumors	154	China	clinicaltrials.gov
November 2, 2026	NCT07910526	Umbilical Cord Mesenchymal Stem Cell Secretome in Patients With Sjogren's Syndrome	Universitas Sebelas Maret Hospital	Phase 1/2	Completed	Sjogren's Syndrome	29	Indonesia	clinicaltrials.gov
November 2, 2026	NCT07909031	CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors	Crescent Biopharma, Inc.	Phase 1/2	Recruiting	Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)...	219	United States	clinicaltrials.gov
November 2, 2026	NCT07908524	MK-2870-U01 Substudy 1: A Clinical Trial of Sacituzumab Tirumotecan to Treat Prostate Cancer (MK-2870-01A)	Merck Sharp & Dohme LLC	Phase 1/2	Not yet recruiting	Metastatic Castration-resistant Prostate Cancer	290		clinicaltrials.gov
October 30, 2026	NCT07907588	Effect of Bee Venom on T Regulatory Cells and Inflammation in Hemodialysis Patients: a Prospective Study Thesis	Mansoura University	Phase 1/2	Completed	Hemodialysis, Inflammation, Regulatory T Cell	60	Egypt	clinicaltrials.gov
October 30, 2026	NCT07906925	Effect of Temperature Elevation on the Antimicrobial Efficacy of Two Root Canal Irrigants in Primary Root Canal Infections: A Randomized...	Tanta University	Phase 1/2	Not yet recruiting	Irreversible Pulpitis	40		clinicaltrials.gov
October 29, 2026	NCT07905261	Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma	Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd	Phase 1/2	Not yet recruiting	Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma	384		clinicaltrials.gov
October 29, 2026	NCT07905131	A Study of Perioperative Navlimetostat Combined With Modified FOLFIRINOX in Patients With MTAP-Deleted Pancreatic Cancer	Daniel Nussbaum, M.D.	Phase 1/2	Not yet recruiting	Pancreatic Ductal Adenocarcinoma (PDAC)	18	United States	clinicaltrials.gov
October 29, 2026	NCT07905105	A Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar Extraction	Cytogel Pharma, LLC	Phase 1/2	Recruiting	Acute Postoperative Pain, Dental Pain	32	United States	clinicaltrials.gov
October 29, 2026	NCT07902921	STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic...	National Cancer Institute (NCI)	Phase 1/2	Not yet recruiting	NSCLC, Non-Small Cell Lung Cancer, Lung Cancer, Prostate Cancer, Thymic Epithelial Tumors, TETs, Thymic Carcinomas...	67	United States	clinicaltrials.gov
October 28, 2026	NCT07902037	A Study of SRN-101 Gene Therapy in Adults With Recurrent High-Grade Glioma (ALERT-1)	Siren Biotechnology	Phase 1/2	Not yet recruiting	Recurrent High Grade Gliomas, Glioblastoma (GBM), Astrocytoma, Oligodendroglioma, Diffuse Hemispheric Glioma	40		clinicaltrials.gov
October 28, 2026	NCT07901595	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2...	Paulex Bio Inc.	Phase 1/2	Not yet recruiting	Healthy Volunteers and Diabetes Participants	147		clinicaltrials.gov
October 28, 2026	NCT07901413	Evaluation of ICP-B381 in Patients With Advanced Solid Tumors	Beijing InnoCare Pharma Tech Co., Ltd.	Phase 1/2	Not yet recruiting	Advanced Solid Tumor	348	China	clinicaltrials.gov
October 28, 2026	NCT07901309	Efficacy and Safety of Dapagliflozin as an Adjunct to Conventional Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid...	Tanta University	Phase 1/2	Not yet recruiting	Rheumatoid Arthritis (RA	100	Egypt	clinicaltrials.gov
October 28, 2026	NCT07900165	Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal Cancer	CytomX Therapeutics	Phase 1/2	Not yet recruiting	Colo-rectal Cancer	368		clinicaltrials.gov
October 28, 2026	NCT07899996	A Study of HB0056 in Adult Participants With Moderate to Severe Asthma	Shanghai Huaota Biopharmaceutical Co., Ltd.	Phase 1/2	Recruiting	Asthma	160	China	clinicaltrials.gov
October 28, 2026	NCT07899983	Effect of Povidone Iodine on the Dental Implant Internal Surface Microbiome	Madigan Army Medical Center	Phase 1/2	Not yet recruiting	Dental Implant	60	United States	clinicaltrials.gov
October 27, 2026	NCT07899632	A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid Tumors	Medsyn Biopharma, LLC	Phase 1/2	Not yet recruiting	Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic, Ovarian Cancer...	75		clinicaltrials.gov
October 27, 2026	NCT07897981	High-Plant-Protein-Diet or High-Animal-Protein-Diet for Improving Alcoholic Fatty Liver Disease	Li Lab,MD	Phase 1/2	Recruiting	Alcohol-associated Fatty Liver Disease	74	China	clinicaltrials.gov
October 27, 2026	NCT07897734	TNG462-C103: Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Vopimetostat in Combination With ERAS-0015 in PDAC and...	Tango Therapeutics, Inc.	Phase 1/2	Not yet recruiting	PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC, RAS Mutation, MTAP Deletion, Lung Cancer, Pancreatic Cancer...	188		clinicaltrials.gov
October 27, 2026	NCT07897448	A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)	Grand Theravac Life Sciences (Hangzhou) Co., Ltd.	Phase 1/2	Not yet recruiting	Chronic Hepatitis B	105		clinicaltrials.gov
October 27, 2026	NCT07897383	Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and Obesity	University Hospital, Gentofte, Copenhagen	Phase 1/2	Not yet recruiting	Obesity & Overweight	18		clinicaltrials.gov
October 27, 2026	NCT07897227	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SYS6062 in Patients With Advanced Solid Tumors.	CSPC Megalith Biopharmaceutical Co.,Ltd.	Phase 1/2	Not yet recruiting	Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)	260		clinicaltrials.gov
October 27, 2026	NCT07896941	Safety and Efficacy of CG-BM1 in Ischemic Stroke	GuangZhou Cellgenes Biotechnology Co., Ltd.	Phase 1/2	Recruiting	Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)	87	China	clinicaltrials.gov
October 26, 2026	NCT07894887	EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)	Editas Medicine, Inc.	Phase 1/2	Not yet recruiting	Heterozygous Familial Hypercholesterolemia (HeFH)	56	Australia	clinicaltrials.gov
October 23, 2026	NCT07893288	A Study of Single and Combination Lipase Dietary Supplements to Increase Fatty Acid Absorption in Generally Health Adults	Danisco	Phase 1/2	Not yet recruiting	Digestive Symptoms, Gastrointestinal Symptoms, Healthy, Impaired Pancreatic Function	50	Canada	clinicaltrials.gov
October 23, 2026	NCT07893171	Study of CM529D1 in Participants With Advanced Solid Tumors	Keymed Biosciences Co.Ltd	Phase 1/2	Not yet recruiting	Advanced Solid Tumors	128	China	clinicaltrials.gov
October 23, 2026	NCT07892989	Immunogenicity and Safety of SYS6052 in the Participants Aged 40 Years and Above	CSPC Megalith Biopharmaceutical Co.,Ltd.	Phase 1/2	Not yet recruiting	Herpes Zoster	496		clinicaltrials.gov
October 23, 2026	NCT07891104	A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed	Institute of Medical Biology, Chinese Academy of Medical Sciences	Phase 1/2	Recruiting	Diphtheria, Pertussis, Tetanus, Poliomyelitis, Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines	380	China	clinicaltrials.gov
October 22, 2026	NCT07890714	A Study of Dato-DXd in Participants With Solid Tumors [TROPION-PanTumor04 (TP04)]	Daiichi Sankyo	Phase 1/2	Recruiting	Urothelial Cancer, Non-small Cell Lung Cancer	268	Taiwan	clinicaltrials.gov
October 22, 2026	NCT07890701	A Single-Arm,Multicenter Phase, Phase II Clinical Trial of Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent...	Second Affiliated Hospital of Wenzhou Medical University	Phase 1/2	Enrolling by invitation	Histiocytosis,Langerhans-Cell	2	China	clinicaltrials.gov
October 22, 2026	NCT07890025	CD19 CAR-T Cell Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Phase I/II Study	Hospital Universitario Dr. Jose E. Gonzalez	Phase 1/2	Not yet recruiting	Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia	30	Mexico	clinicaltrials.gov
October 22, 2026	NCT07889232	Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer	VA Office of Research and Development	Phase 1/2	Not yet recruiting	Metastatic Non-Small Cell Lung Cancer, Cancer-Associated Weight Loss, Elevated Inflammatory Markers	43	United States	clinicaltrials.gov
October 22, 2026	NCT07888686	Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV)...	Serum Institute of India Pvt. Ltd.	Phase 1/2	Not yet recruiting	Human Papillomavirus Infection	72	Australia	clinicaltrials.gov
October 22, 2026	NCT07888348	Anakinra for Prevention of Poor Graft Function in MDS Allo-HSCT	Ruijin Hospital	Phase 1/2	Not yet recruiting	Poor Graft Function, Myelodysplastic Syndromes, Hematopoietic Stem Cell Transplantation	66	China	clinicaltrials.gov
October 21, 2026	NCT07887750	REGN9220 in Combination With Odronextamab in Adult Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas (BCNHLs)	Regeneron Pharmaceuticals	Phase 1/2	Not yet recruiting	Diffuse Large B-Cell Lymphoma (DLBCL)	36		clinicaltrials.gov
October 21, 2026	NCT07887347	A Study of the Safety and Efficacy of Prime Editing (PM647a) in Participants With Alpha-1 Antitrypsin Deficiency	Prime Medicine, Inc.	Phase 1/2	Not yet recruiting	Alpha-1 Antitrypsin Deficiency, Alpha-1 Antitrypsin Deficiency-associated Lung Disease, Alpha-1 Antitrypsin Deficiency...	54		clinicaltrials.gov
October 21, 2026	NCT07886684	A Clinical Trial to Test if the Investigational Drug BNT3210 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known...	BioNTech SE	Phase 1/2	Not yet recruiting	Advanced Solid Tumors	173		clinicaltrials.gov
October 21, 2026	NCT07885683	MagSense® Human Epidermal Growth Factor Receptor 2 (HER2) Imaging Agent (MSH2IA)	Imagion Biosystems, Inc.	Phase 1/2	Not yet recruiting	HER2-positive Breast Cancer	70		clinicaltrials.gov
October 21, 2026	NCT07885397	Sonrotoclax Plus Azacitidine in Patients With MDS-IB2	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Phase 1/2	Recruiting	Myelodysplastic Syndromes, High Risk	60	China	clinicaltrials.gov
October 21, 2026	NCT07885319	Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma	Ruijin Hospital	Phase 1/2	Recruiting	Malignant Pleural Mesothelioma, Advanced	78	China	clinicaltrials.gov
October 21, 2026	NCT07885228	Jaktinib for Steroid-Refractory Acute Graft-Versus-Host Disease	Nanfang Hospital, Southern Medical University	Phase 1/2	Not yet recruiting	Acute Graft vs Host Disease	49	China	clinicaltrials.gov
October 20, 2026	NCT07883382	An Exploratory Study on the Use of Gecacitinib in Patients With Myeloid Malignancies and Myelofibrosis During the Peri-transplant Period...	Ruijin Hospital	Phase 1/2	Recruiting	Myeloid Neoplasms With Myelofibrosis	10	China	clinicaltrials.gov
October 20, 2026	NCT07882641	BEX101 in B-cell Non-Hodgkin's Lymphoma	Chinese PLA General Hospital	Phase 1/2	Recruiting	Non-Hodgkin's Lymphoma	20	China	clinicaltrials.gov
October 19, 2026	NCT07880873	Defibrio AED Study	Defibrio, LLC	Phase 1/2	Not yet recruiting	VF, VT	25		clinicaltrials.gov
October 16, 2026	NCT07879495	Alveolar Ridge Preservation (ARP) Study Using Alloplastic Biomaterial and a Resorbable Synthetic Membrane. A Digital Workflow...	Universidad Católica San Antonio de Murcia	Phase 1/2	Not yet recruiting	Alveolar Ridge Augmentation, Bone Substitutes, Guided Tissue Regeneration, Periodontal, Cone-Beam Computed Tomography...	28		clinicaltrials.gov
October 16, 2026	NCT07878689	Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma	University of Texas Southwestern Medical Center	Phase 1/2	Not yet recruiting	Hepatocellular Carcinoma (HCC)	36	United States	clinicaltrials.gov
October 16, 2026	NCT07877701	Acute Nicotine Gum and Auditory Brain Responses in Adults With Chronic Tinnitus	San Diego State University	Phase 1/2	Not yet recruiting	Tinnitus, Chronic Subjective Tinnitus	20	United States	clinicaltrials.gov
October 16, 2026	NCT07877610	CARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and Adults	Fondazione Matilde Tettamanti Menotti De Marchi Onlus	Phase 1/2	Recruiting	AML (Acute Myeloid Leukemia), BPDCN	18	Italy	clinicaltrials.gov
October 15, 2026	NCT07876856	A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)	Ausper Biopharma Co., Ltd.	Phase 1/2	Not yet recruiting	Chronic Hepatitis B	105		clinicaltrials.gov
October 15, 2026	NCT07876804	A Long-term Follow-up Study in Male Participants With X-linked Myotubular Myopathy Treated With ASP2957	Astellas Gene Therapies	Phase 1/2	Not yet recruiting	X-linked Myotubular Myopathy	9		clinicaltrials.gov
October 15, 2026	NCT07876128	A Clinical Trial of MK-2750 in Participants With Advanced Solid Tumors (MK-2750-002)	Merck Sharp & Dohme LLC	Phase 1/2	Not yet recruiting	Advanced Solid Tumors, Malignant Neoplasm	300		clinicaltrials.gov
October 14, 2026	NCT07874347	Home-Based Outpatient Model for BCG Delivery to Reduce Undue Burden on Patients Undergoing Treatment for Non-Muscle Invasive Bladder...	Ohio State University Comprehensive Cancer Center	Phase 1/2	Not yet recruiting	Non-Muscle Invasive Bladder Carcinoma	49	United States	clinicaltrials.gov
October 14, 2026	NCT07873827	KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme Malignancies	Stemline Therapeutics, Inc.	Phase 1/2	Not yet recruiting	Hematological Malignancy	115		clinicaltrials.gov
October 14, 2026	NCT07873450	SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET	Full-Life Technologies UK Limited	Phase 1/2	Recruiting	Solid Tumor, NSCLC, Colorectal Cancer, Head and Neck Cancer, Cholangiocarcinoma	208	Australia, United States	clinicaltrials.gov
October 13, 2026	NCT07871890	A Study to Investigate Small Mobile Stem Cells (SMS) in Moderate to Severe Chronic Obstructive Pulmonary Disease	SMSbiotech	Phase 1/2	Not yet recruiting	Chronic Obstructive Lung Disease	125	United States	clinicaltrials.gov
October 13, 2026	NCT07871877	Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder	Clive Michelsen	Phase 1/2	Not yet recruiting	Opioid Use Disorder, Opioid Withdrawal, Substance Use Disorders	60	United States	clinicaltrials.gov
October 13, 2026	NCT07871435	GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC)...	GI Innovation, Inc.	Phase 1/2	Recruiting	Metastatic Castration-resistant Prostate Cancer (mCRPC)	107	South Korea, United States	clinicaltrials.gov
October 13, 2026	NCT07871006	Ofatumumab in Treatment-Refractory¬ Narcolepsy Type 1	Xijing Hospital	Phase 1/2	Recruiting	Narcolepsy Type 1 (NT1)	20	China	clinicaltrials.gov
October 13, 2026	NCT07870447	Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control After Pediatric Adenotonsillectomy	NYU Langone Health	Phase 1/2	Not yet recruiting	Adenotonsillectomy, Postoperative Pain	500	United States	clinicaltrials.gov
October 13, 2026	NCT07869953	Oftac Eye Drops (0.05% Tacrolimus Ophthalmic Emulsion) for the Treatment of Active Non-infectious Anterior Uveitis	BioNanoSim Ltd.	Phase 1/2	Completed	Non-Infectious Anterior Uveitis	18	Israel	clinicaltrials.gov
October 9, 2026	NCT07868172	GST101 in Participants With RAS-Mutant Advanced Solid Tumors	Genuine Seed Therapeutics (Zhuhai) Co., Ltd.	Phase 1/2	Recruiting	RAS-mutant Advanced Solid Tumors	172	China	clinicaltrials.gov
October 8, 2026	NCT07865780	Photobiomodulation Alone Versus Photobiomodulation Combined With Topical Oral Oxygen Therapy for Radiotherapy-Induced Oral Mucositis in...	Assiut University	Phase 1/2	Enrolling by invitation	Mucositis Oral, Head & Neck Cancer	46	Egypt	clinicaltrials.gov
October 8, 2026	NCT07865676	Clinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia	GuangZhou Cellgenes Biotechnology Co., Ltd.	Phase 1/2	Recruiting	Sarcopenia	30	China	clinicaltrials.gov
October 8, 2026	NCT07864701	Study of JMBI-001 in Patients With MYC-Positive Advanced Cancers	Chengdu Anticancer Bioscience, Ltd.	Phase 1/2	Recruiting	Advance Solid Tumors, Lymphoma, Non-Hodgkin	150	China	clinicaltrials.gov
October 8, 2026	NCT07864584	Study Using a Drug-device Combination Product to Determine Safety, Tolerability and Antitumor Activity for Patients With Advanced...	Nob Hill Therapeutics, Inc.	Phase 1/2	Not yet recruiting	NSCLC (Advanced Non-small Cell Lung Cancer)	100	United States	clinicaltrials.gov
October 7, 2026	NCT07864207	Phase 1/2 Multicenter, Open-label, Dose-escalation Study of IDP- 121 in Patients With Platinum-resistant Small Cell Lung Cancer (MYCrocytic)	IDP Discovery Pharma S.L.	Phase 1/2	Recruiting	Small Cell Lung Cancer ( SCLC )	60	Spain	clinicaltrials.gov
October 7, 2026	NCT07864181	TheraCal PT vs. Formocresol in Primary Molar Pulpotomies	Hama University	Phase 1/2	Completed	Reversible Pulpitis	50	Syria	clinicaltrials.gov
October 7, 2026	NCT07863869	The QL1706 Combined With Chemotherapy and Either Cetuximab or Bevacizumab in Potentially Resectable Colorectal Cancer Patients With Liver...	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 1/2	Not yet recruiting	Colorectal Cancer Metastatic to Liver	102		clinicaltrials.gov
October 7, 2026	NCT07863180	Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial	Prabesh Kanel	Phase 1/2	Recruiting	Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy(PSP)	15	United States	clinicaltrials.gov
October 7, 2026	NCT07863024	Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET...	Regeneron Pharmaceuticals	Phase 1/2	Not yet recruiting	Advanced Solid Tumors	320		clinicaltrials.gov
October 7, 2026	NCT07862582	RYZ711 Diagnostic Platform Study	RayzeBio, Inc.	Phase 1/2	Not yet recruiting	Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer...	116	United States	clinicaltrials.gov
October 7, 2026	NCT07862335	Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers	Tiger Biosciences, LLC.	Phase 1/2	Not yet recruiting	Lower Extremity, Chronic Ulcers, Pressure Ulcer (PU), Venous Leg Ulcer (VLU), Wound Management	30		clinicaltrials.gov
October 6, 2026	NCT07861932	A Phase 1/2a Study of K-1728 in Advanced Solid Tumors	KymaThera, Inc.	Phase 1/2	Not yet recruiting	Breast Neoplasms, Solid Tumors, PIK3CA Gene Mutation	110		clinicaltrials.gov
October 5, 2026	NCT07859358	Injectable Platelet-Rich Fibrin (i-PRF) and Oxygen-Releasing Gel in the Treatment of Stage II Periodontitis.	Assiut University	Phase 1/2	Completed	Stage III Periodontitis	24	Egypt	clinicaltrials.gov
October 5, 2026	NCT07859059	Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/Glioblastoma	University of Nebraska	Phase 1/2	Not yet recruiting	High Grade Glioma, Glioblastoma, Gliosarcoma	41	United States	clinicaltrials.gov
October 5, 2026	NCT07858643	A Study of LDGraft In Single Level Lumbar Interbody Fusion	Locate Bio Ltd	Phase 1/2	Recruiting	Degenerative Disc Disease Lumbar	25	Georgia	clinicaltrials.gov
October 5, 2026	NCT07857135	A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SYS6088 in Patients With Advanced/Metastatic Solid Tumors	CSPC Megalith Biopharmaceutical Co.,Ltd.	Phase 1/2	Not yet recruiting	Advanced/Metastatic Solid Tumors	140		clinicaltrials.gov
October 2, 2026	NCT07856082	Opt-IVF for Personalized Medicine for Normal Responders	Urmila DIwekar	Phase 1/2	Active not recruiting	Ivf	100	United States	clinicaltrials.gov
October 2, 2026	NCT07855211	A Study to Learn About the Safety of BIIB147 and Its Effects in Adults With Amyotrophic Lateral Sclerosis (ALS)	Biogen	Phase 1/2	Recruiting	Amyotrophic Lateral Sclerosis	69	United States	clinicaltrials.gov
October 2, 2026	NCT07855172	Safety and Immunogenicity of a Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Recombinant Poliomyelitis and Haemophilus...	Serum Institute of India Pvt. Ltd.	Phase 1/2	Not yet recruiting	Diptheria Immunization, Tetanus Immunization, Pertussis Immunization, Hepatitis B Immunization, Haemophilus...	186	Bangladesh	clinicaltrials.gov
October 1, 2026	NCT07853105	Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With...	University Hospital, Strasbourg, France	Phase 1/2	Not yet recruiting	Osteosarcomas, Bone Cancer, Ewing Sarcomas	89	France	clinicaltrials.gov
October 1, 2026	NCT07852650	Digital STEADI Efficacy	Friendi.fi Corporation	Phase 1/2	Recruiting	Fall, Mild Cognitive Impairment (MCI), Aging	300	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Beijing Biotech	28	August 4, 2026
AstraZeneca	20	July 21, 2026
M.D. Anderson Cancer Center	19	October 1, 2026
Institute of Hematology & Blood Diseases Hospital, China	19	August 11, 2026
Merck Sharp & Dohme LLC	18	November 2, 2026
West China Hospital	17	September 23, 2026
Peking Union Medical College Hospital	16	September 23, 2026
n-Lorem Foundation	16	August 3, 2026
GlaxoSmithKline	16	June 4, 2026
Ruijin Hospital	15	October 22, 2026
Sun Yat-sen University	14	May 29, 2026
National Cancer Institute (NCI)	13	October 29, 2026
Jiangsu HengRui Medicine Co., Ltd.	13	September 8, 2026
Novartis Pharmaceuticals	13	May 6, 2026
BioNTech SE	12	October 21, 2026
Memorial Sloan Kettering Cancer Center	12	September 14, 2026
Qilu Pharmaceutical Co., Ltd.	12	July 29, 2026
CSPC Megalith Biopharmaceutical Co.,Ltd.	11	October 27, 2026
Regeneron Pharmaceuticals	11	October 21, 2026
Sinocelltech Ltd.	11	September 14, 2026

Conditions

Condition group	New trials	Latest
Carcinoma, Non-Small-Cell Lung	101	November 3, 2026
Colorectal Neoplasms	77	November 3, 2026
Breast Neoplasms	67	October 6, 2026
Recurrence	62	November 2, 2026
Neoplasms	59	November 6, 2026
Pancreatic Neoplasms	59	October 29, 2026
Prostatic Neoplasms	53	November 4, 2026
Neoplasm Metastasis	47	November 2, 2026
Ovarian Neoplasms	46	November 2, 2026
Stomach Neoplasms	43	October 27, 2026
Multiple Myeloma	41	November 3, 2026
Leukemia, Myeloid, Acute	36	November 9, 2026
Squamous Cell Carcinoma of Head and Neck	36	November 5, 2026
Melanoma	33	September 25, 2026
Small Cell Lung Carcinoma	32	October 7, 2026
Carcinoma, Hepatocellular	29	October 16, 2026
Glioblastoma	28	October 28, 2026
Lung Neoplasms	27	October 29, 2026
Triple Negative Breast Neoplasms	27	October 27, 2026
Endometrial Neoplasms	24	November 2, 2026
Lymphoma	24	February 13, 2026
Obesity	23	October 27, 2026
Lymphoma, Large B-Cell, Diffuse	21	October 21, 2026
Parkinson Disease	20	November 6, 2026
Lymphoma, B-Cell	20	October 29, 2026

By country

Country	New trials	Latest
China	802	November 9, 2026
United States	721	November 9, 2026
Australia	154	November 6, 2026
Spain	133	October 7, 2026
France	103	October 1, 2026
United Kingdom	102	September 16, 2026
Canada	93	October 23, 2026
South Korea	88	October 13, 2026
Italy	73	October 16, 2026
Germany	73	September 28, 2026
Japan	70	November 3, 2026
Egypt	50	October 30, 2026
Taiwan	49	October 22, 2026
Brazil	42	August 25, 2026
Netherlands	41	September 28, 2026
Israel	36	October 13, 2026
Belgium	36	September 28, 2026
Poland	32	September 28, 2026
Turkey (Türkiye)	25	July 31, 2026
New Zealand	24	September 21, 2026
Sweden	20	August 17, 2026
Denmark	20	June 9, 2026
Singapore	19	August 26, 2026
Pakistan	15	September 8, 2026
Norway	15	May 12, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.